The new market intelligence report by Persistence Market Research (PMR) reveals that theglobal pyrogen testing market<\/strong>willreach US$ ~800 Mn<\/strong>by the end of 2019, and further exhibit arobust CAGR of 9%<\/strong>through the next decade.<\/p>\n The increasing trend of outsourcing drug manufacturing to low-cost production regions by most pharmaceutical companies has been touted to remain a major influencer associated with the growth of pyrogen testing market landscape over the period of assessment, as it allows for low-cost skilled workforce and ease in tax relaxation.<\/p>\n Get Sample Copy of Report @https:\/\/www.persistencemarketresearch.com\/samples\/4259<\/a><\/strong><\/p>\n Company Profiles:<\/strong><\/p>\n Growing Number of Pharmaceutical and Biotechnology Companies to Bring Traction to Pyrogen Testing<\/strong><\/p>\n As medical devices cross the barriers within the body leading to contamination, pyrogen testing could be used by healthcare professionals to detect the harmful substances present in those devices. In addition, growing healthcare awareness also leads to upsurge in the medicine demand, which increases establishment of pharmaceuticals and biotechnology industries.<\/p>\n This in turn, propels the demand for pyrogen testing in these establishments worldwide. Moreover, increase in number of people diagnosed with various diseases results in the rising demand for various injectables, vaccines, tablets, and other medicines in turn, fueling the demand for safety measures such as pyrogen testing.<\/p>\n According to the PMR analysis, in end user, pharmaceutical companies will dominate the demand side in the pyrogen testing market by the end of 2019 and will also continue to exploit the highest share in the forecast period.<\/p>\n This is due to the growing number of pharmaceutical establishments in developed as well as developing countries, which increases the need for drug safety checks like pyrogen testing.<\/p>\n Demand for limulus amebocyte lysate (LAL) pyrogen testing is estimated to grow by the end of 2029, as end users demands for user-friendly pyrogen testing method that are cost-effective, and incur low equipment cost as well. Thus, the PMR study report estimates that LAL pyrogen testing method will harness around 60% of the global pyrogen testing market share during the forecast period.<\/p>\n Get To Know Methodology of Report @https:\/\/www.persistencemarketresearch.com\/methodology\/4259<\/a><\/strong><\/p>\n Favorable Government Initiatives to Augur Well for Pyrogen Testing Market<\/strong><\/p>\n Increasing spending by government bodies to develop effective drugs and medical devices is expected to drive the growth of the global pyrogen testing market in the forecast period. Pyrogen is a prominent cause that leads to shock or fatality among a large section of the patient population creating an economic burden on the country.<\/p>\n Thus, increasing healthcare spending is expected to result in growing demand for pyrogen testing by various pharmaceutical and medical device companies. Also, government in various countries are focused on prevention of infectious diseases to reduce associated healthcare costs, which in turn is expected to result in high demand for healthcare facilities.<\/p>\n In order to further complement this, government is focusing on pyrogen testing policies for contaminant-free medical devices and pharmaceuticals provided to the patient population, which will pave the way for the elevated requirement of pyrogen testing in the market.<\/p>\n Access Full Report @https:\/\/www.persistencemarketresearch.com\/checkout\/4259<\/a><\/strong><\/p>\n Hence, companies operating in the pyrogen testing market are expected to largely benefit from such developments.<\/p>\n PMR’s analysis also projects groundbreaking perspectives on the competitive business scenario of the pyrogen testing market along with highlights of participants’ key business policies and approaches.<\/p>\n For instance, many drug manufacturing units are investing in foreign nations, especially in emerging economies of Asia Pacific and Latin America, which hold great future opportunities for the pyrogen testing market. Various pharmaceutical and medical device manufacturers are establishing their manufacturing base in India, China, and others in order to tap and cater to the unmet needs of the patient population in these regions, thus escalating the market for pyrogen testing.<\/p>\n<\/div>\n Explore Extensive Coverage of PMR`sLife Sciences & Transformational Health<\/a>Landscape<\/strong><\/p>\n Molecular Diagnostics Market –<\/strong><\/p>\n Molecular Diagnostics Market<\/a>Segmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.<\/p>\n Next-Generation Sequencing Market –<\/strong><\/p>\n Next Generation Sequencing Market<\/a>Segmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.<\/p>\n Ophthalmology devises Market –<\/strong><\/p>\n Ophthalmology devises Market<\/a>Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.<\/p>\n Intravenous Iron Drugs Market –<\/strong><\/p>\n Intravenous (IV) Iron Drugs Market<\/a>Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A\/S, Rockwell Medical Technologies, Inc., and Sanofi.<\/p>\n Syndromes Progressive Ataxia Weakness Disorders Market –<\/strong><\/p>\n Treatments forSyndromes of Progressive Ataxia and Weakness Disorders Market<\/a>Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.<\/p>\n About us:<\/strong><\/p>\n Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.<\/p>\n To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.<\/p>\n Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.<\/p>\n Contact us:<\/strong><\/p>\n 305 Broadway, 7th Floor Tags: Pyrogen Testing Market Demand<\/a>, Pyrogen Testing Market Development<\/a>, Pyrogen Testing Market Revenue Share<\/a>, Pyrogen Testing Market Supply<\/a>, Pyrogen Testing Market Analysis<\/a>, Pyrogen Testing Market Forecast<\/a>, Pyrogen Testing Market Growth<\/a>, Pyrogen Testing Market Size<\/a>, Pyrogen Testing Market Trends<\/a><\/p>\n 305 Broadway, 7th Floor Tags:<\/b> 305 Broadway, 7th Floor![\"global](\"https:\/\/www.persistencemarketresearch.com\/images\/global-pyrogen-testing-market.jpg\" "\\"Global")
<\/p>\n\n
\nNew York City, NY 10007
\nUnited States
\nPh.no. +1-646-568-7751
\nE-mail id-sales@persistencemarketresearch.com<\/a>
\nWebsite:https:\/\/www.persistencemarketresearch.com<\/a><\/p>\n
Contact Information:<\/b><\/p>\n
New York City, NY 10007
United States
Ph.no.<\/strong> +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com<\/a><\/strong>
Website: https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n
<\/a>, Extended Distribution<\/a>, Research Newswire<\/a>, English<\/a><\/p>\n<\/div>\n
Contact Information:<\/h3>\n
New York City, NY 10007
United States
Ph.no.<\/strong> +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com<\/a><\/strong>
Website: https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/04\/4027-1588091174.png\")
The new market intelligence report by Persistence Market Research (PMR) reveals that the global pyrogen testing market will reach US$ ~800 Mn by the end of 2019, and further exhibit a robust CAGR of 9% through the next decade. The increasing trend of outsourcing drug manufacturing to low-cost production regions by most pharmaceutical companies has been touted to remain a major … Continue reading Pyrogen Testing Market to Register CAGR 9% Growth in Revenue During the Forecast Period 2029<\/span><\/a> Continue Reading
<\/p>\n